Warning! GuruFocus detected
3 Severe warning signs
with 4LL.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Teladoc Health Inc
NAICS : 621999
SIC : 8011
ISIN : US87918A1051
Description
Teladoc Health Inc is engaged in virtual care, forging a new healthcare experience with Better convenience, outcomes, and value. Its mission is to empower all people everywhere to live their healthiest lives by transforming the healthcare experience. It operates in Teladoc two segments Health Integrated Care and BetterHelp segments. The majority of its revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.82 | |||||
| Equity-to-Asset | 0.42 | |||||
| Debt-to-Equity | 1.06 | |||||
| Debt-to-EBITDA | -2.7 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -5.98 | |||||
| Beneish M-Score | -3.3 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 5.2 | |||||
| 3-Year EBITDA Growth Rate | -86 | |||||
| 3-Year EPS without NRI Growth Rate | 4.3 | |||||
| 3-Year FCF Growth Rate | 6.3 | |||||
| 3-Year Book Growth Rate | -55.9 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 26.57 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 27.09 | |||||
| 9-Day RSI | 31.75 | |||||
| 14-Day RSI | 35.37 | |||||
| 3-1 Month Momentum % | 5.22 | |||||
| 6-1 Month Momentum % | 27.67 | |||||
| 12-1 Month Momentum % | -32.58 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.77 | |||||
| Quick Ratio | 1.73 | |||||
| Cash Ratio | 1.38 | |||||
| Days Inventory | 16.69 | |||||
| Days Sales Outstanding | 30.58 | |||||
| Days Payable | 20.25 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -2.6 | |||||
| Shareholder Yield % | -0.12 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 70.76 | |||||
| Operating Margin % | -8.13 | |||||
| Net Margin % | -38.97 | |||||
| FCF Margin % | 6.6 | |||||
| ROE % | -54.92 | |||||
| ROA % | -25.96 | |||||
| ROIC % | -7.41 | |||||
| 3-Year ROIIC % | -0.4 | |||||
| ROC (Joel Greenblatt) % | -1486.65 | |||||
| ROCE % | -30.95 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.54 | |||||
| PB Ratio | 0.94 | |||||
| Price-to-Free-Cash-Flow | 8.2 | |||||
| Price-to-Operating-Cash-Flow | 4.72 | |||||
| EV-to-EBIT | -1.74 | |||||
| EV-to-Forward-EBIT | -27.73 | |||||
| EV-to-EBITDA | -2.88 | |||||
| EV-to-Forward-EBITDA | 7.27 | |||||
| EV-to-Revenue | 0.66 | |||||
| EV-to-Forward-Revenue | 0.67 | |||||
| EV-to-FCF | 9.97 | |||||
| Price-to-GF-Value | 0.34 | |||||
| Price-to-Projected-FCF | 0.66 | |||||
| Price-to-Median-PS-Value | 0.06 | |||||
| Earnings Yield (Greenblatt) % | -57.47 | |||||
| FCF Yield % | 12.07 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Teladoc Health Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 2,380.038 | ||
| EPS (TTM) (€) | -5.46 | ||
| Beta | 1.85 | ||
| 3-Year Sharpe Ratio | -0.82 | ||
| 3-Year Sortino Ratio | -0.96 | ||
| Volatility % | 61.6 | ||
| 14-Day RSI | 35.37 | ||
| 14-Day ATR (€) | 0.442411 | ||
| 20-Day SMA (€) | 8.19635 | ||
| 12-1 Month Momentum % | -32.58 | ||
| 52-Week Range (€) | 6.101 - 14.25 | ||
| Shares Outstanding (Mil) | 173.67 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Teladoc Health Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Teladoc Health Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Teladoc Health Inc Frequently Asked Questions
What is Teladoc Health Inc(FRA:4LL)'s stock price today?
The current price of FRA:4LL is €7.50. The 52 week high of FRA:4LL is €14.25 and 52 week low is €6.10.
When is next earnings date of Teladoc Health Inc(FRA:4LL)?
The next earnings date of Teladoc Health Inc(FRA:4LL) is 2025-04-25 Est..
Does Teladoc Health Inc(FRA:4LL) pay dividends? If so, how much?
Teladoc Health Inc(FRA:4LL) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers